Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sylvia Innocentin"'
Autor:
Vasco Azevedo, P. Langella, Anderson Miyoshi, Sylvia Innocentin, Jean-Marc Chatel, Denis Mariat, M.S.P. de Azevedo, Daniela Santos Pontes, Fernanda Alves Dorella, Clarissa Santos Rocha
Publikováno v:
Journal of Applied Microbiology
Journal of Applied Microbiology, Wiley, 2013, 115 (2), pp.319-333. ⟨10.1111/jam.12174⟩
Journal of Applied Microbiology, Wiley, 2013, 115 (2), pp.319-333. ⟨10.1111/jam.12174⟩
Allergic diseases affect up to 30% of the western population, and their prevalence is increasing. Probiotics are able to modulate the mucosal immune response, and clinical trials demonstrated that specific strains, especially lactic acid bacteria (LA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff4fefcb8c2a8dbd263af2f4f87b1b3
https://doi.org/10.1111/jam.12174
https://doi.org/10.1111/jam.12174
Autor:
Vasco Azevedo, François Lefèvre, Jean-Marc Chatel, Anderson Miyoshi, Sylvia Innocentin, Valeria Guimarães, Philippe Langella
Publikováno v:
Genetic Vaccines and Therapy
Genetic Vaccines and Therapy, BioMed Central, 2009, 7 (4), 7 p. ⟨10.1186/1479-0556-7-4⟩
Genetic Vaccines and Therapy 4 (7), 7 p.. (2009)
Genetic Vaccines and Therapy, BioMed Central, 2009, 7 (4), 7 p. ⟨10.1186/1479-0556-7-4⟩
Genetic Vaccines and Therapy 4 (7), 7 p.. (2009)
Background The use of food-grade lactococci as bacterial carriers to DNA delivery into epithelial cells is a new strategy to develop live oral DNA vaccine. Our goal was to develop a new plasmid, named pValac, for antigen delivery for use in lactococc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340549a6faa993a75b882f10cccd618a
https://pubmed.ncbi.nlm.nih.gov/19208231
https://pubmed.ncbi.nlm.nih.gov/19208231